FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • News
✕

Prof. Langmann wins the Dr. Gaide AMD prize

Augenklinik

On 23 June 2018, Univ.-Prof. Dr. rer. nat. Thomas Langmann was awarded the Dr. Gaide AMD prize at the annual meeting of the Retina Society in Bonn. Prof. Langmann is the Chair of Experimental Immunology of the Eye in the Department of Ophthalmology, Medical Faculty, University of Cologne and Vice-Speaker of the DFG Research Unit For 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” based in Cologne.
The prize is endowed with a 10,000 euro award for excellence in research in the area of age-related macula degeneration (AMD), which is the primary cause of blindness for patients over the age of 60 in Western industrialized nations. As yet, there is no therapy for the so-called dry form of AMD, which leads to a high level of suffering for patients.
Prof. Langmann and his team are studying an inhibitor of chronic inflammation in the retina, the layers of tissue on the inner surface of the eyeball specialized for transforming light stimuli into nerve impulses. With AMD, so-called galectins are released, which are sugary protein molecules. If a harmonious way of blocking this process with drugs is found, then it will be possible to slow down the progression of AMD.

[This article is based in part on the German language item appearing on the website of University Hospital of Cologne on 2 July 2018:
http://intranet.uk-koeln.de/aktuelles-termine/uniklinik-intern/detailansicht/?tx_ttnews%5Btt_news%5D=1606&cHash=e68904bb7076b1f233855eb57e25f570]

Related posts

July 28, 2023

Modern laboratory – microscope donated


Read more
January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more

News

  • SFB 1607 Launches Website and Celebrates TEO-C New Lab Location
  • New SFB 1607 Launched – Building on the Foundations of FOR2240
  • Faculty prize for PD Dr. Schrittenlocher – Awarded for best habilitation in 2022
  • DOG poster award for Dr. Martina Maaß
  • Young Cologne Eye Researcher Šejla Gegić won Margarete Kramer Prize

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck
      Um unsere Website für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies und insb. der Möglichkeiten, der Verwendung von Cookies zu widersprechen, erhalten Sie in unserer Datenschutzerklärung.SchließenDatenschutzerklärung